Analysts/Institutional Investor Meet/Con. Call Updates

September 22, 2026 To, To, The Listing Department, The Listing Department BSE Limited, National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai – 400001 Bandra (East), Mumbai – 400051 Scrip code: 544889 Symbol: SYMBIOTEC Subject: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Audio Recording Link of Earnings Conference Call for Q1 ended June 30, 2026 Dear Sir/ Ma'am, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Audio Recording Link of Earnings Conference Call of all Investors/ General public held today i.e. September 22, 2026 to discuss Operational and Financial Performance of the Company for the 1st Quarter ended June 30, 2026 is available on the website of the Company https://investor.symbiotec.com/performance?tab=quarterly and can be direct accessed via below link: https://cornflowerblue-penguin-553951.hostingersite.com/uploads/1790063932954- 543036402.mp3 You are requested to kindly take the same in your records. Thanking You. Sincerely, For Symbiotec Pharmalab Limited Salil Jain Company Secretary and Compliance Officer Membership No. A41610 Encl: As above Registered Office & Works: Symbiotec Pharmalab Limited (Formerly known as Symbiotec Pharmalab Pvt. Ltd.) 385/2, Pigdamber, Rau, Mhow, Indore - 453331, Madhya Pradesh, India Tel. No.: +91-731-6676405-406 Fax: +91-731-4201222, Email ID : symbiotec@symbiotec.com, Website : www.symbiotec.com CIN: U24232MP2002PLC015293